MediPal Holdings Corporation
MAHLY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -9.30 | 2.01 | 0.29 | 0.69 |
| FCF Yield | 9.53% | 8.55% | 0.72% | 9.13% |
| EV / EBITDA | 2.56 | 4.10 | 2.81 | 3.89 |
| Quality | ||||
| ROIC | 4.58% | 4.14% | 4.57% | 4.27% |
| Gross Margin | 6.97% | 6.93% | 6.31% | 6.23% |
| Cash Conversion Ratio | 0.79 | 1.49 | 0.42 | 2.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.00% | 2.64% | 1.52% | 0.39% |
| Free Cash Flow Growth | 13.38% | 1,506.66% | -93.76% | 125.45% |
| Safety | ||||
| Net Debt / EBITDA | -2.75 | -3.50 | -2.93 | -3.84 |
| Interest Coverage | 7,944.14 | 5,916.38 | 1,440.41 | 2,851.56 |
| Efficiency | ||||
| Inventory Turnover | 19.18 | 19.25 | 18.56 | 19.37 |
| Cash Conversion Cycle | 1.94 | 1.67 | 2.95 | -2.47 |